UBE2D3 and early-onset autosomal dominant Alzheimer disease: Interestingly, this inflammatory pathway is often noted for its association to AD (Tahara et al., 2006; Walter et al., 2007), while UBE2D3 has been proposed as a potential biomarker for Alzheimer’s disease (Wu et al., 2019).